Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus‐1 vector

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Hepatology

• Publication date

  1995-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.1840210324PMID 7875674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Gene Transfer

  1995cited by this paper
• Hepatocyte transplantation: new strategies for hepatic reconstitution and gene therapy.

  1994cited by this paper
• Studies on the Safety of Intrasplenic Hepatocyte Transplantation: Relevance to Ex Vivo Gene Therapy and Liver Repopulation in Acute Hepatic Failure

  1993cited by this paper
• The basic science of gene therapy.

  1993cited by this paper
• Hepatocyte transplantation: prolonged cell survival following ex vivo manipulation and release from culture matrix components.

  1993cited by this paper
• Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector.

  1992cited by this paper
• Strategies for Gene Therapy in the Liver

  1992cited by this paper
• Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia.

  1992cited by this paper
• Transduction of primary human hepatocytes with amphotropic and xenotropic retroviral vectors.

  1992cited by this paper
• Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX.

  1992cited by this paper
• Herpes simplex virus immediate early gene expression in the absence of transinduction by Vmw65 varies during the cell cycle.

  1992cited by this paper
• Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.

  1991cited by this paper
• Herpes simplex virus for gene delivery to neurons.

  1991cited by this paper
• The use of hsv 1 vectors to introduce heterologous genes into neurons implications for gene therapy

  1991cited by this paper
• Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.

  1991cited by this paper
• Permanent engraftment and function of hepatocytes delivered to the liver: Implications for gene therapy and Liver Repopulation

  1991cited by this paper
• Retroviral-mediated gene transfer into hepatocytes in vivo.

  1991cited by this paper
• An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

  1990cited by this paper
• Retrovirus vector-mediated gene transfer into hepatocytes.

  1989cited by this paper
• A Laboratory manual

  1989cited by this paper
• Human herpesviruses: a consideration of the latent state

  1989cited by this paper
• A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.

  1988cited by this paper
• Retrovirus-mediated transduction of adult hepatocytes.

  1988cited by this paper
• Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.

  1987cited by this paper
• Chromosome damage induced by herpes simplex virus type 1 in early infection.

  1986cited by this paper
• Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

  1984cited by this paper
• Electron microscopic observations on primary hepatocyte cultures infected with herpes simplex virus Types I and II

  1984cited by this paper
• The Liver: Biology and Pathobiology

  1983cited by this paper
• Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

  1982cited by this paper
• Eukaryotic viral vectors

  1982cited by this paper
• The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector.

  1982cited by this paper
• A quantitative bioassay for nerve growth factor (NGF) activity employing a clonal pheochromocytoma cell line.

  1977cited by this paper
• Preparation of isolated rat liver cells.

  1976cited by this paper
• ON THE HISTOCHEMICAL DEMONSTRATION OF GLUCOSE-6-PHOSPHATASE

  1956cited by this paper

• chronic lymphocytic leukemia based immunotherapy for - Development of herpes simplex virus-1 amplicon

  2013cites this paper
• Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model

  2013cites this paper
• Gene therapy using herpes simplex virus-based vectors

  2010cites this paper
• Human hepatocyte transplantation: current experience and future challenges

  2010cites this paper
• HSV-1 amplicon vectors

  2007cites this paper
• Assessment of viral and non-viral gene transfer into adult rat brains using HSV-1, calcium phosphate and PEI-based methods.

  2005cites this paper
• Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.

  2005cites this paper
• Transfection of tyrosine kinase deleted FGF receptor-1 into rat brain substantia nigra reduces the number of tyrosine hydroxylase expressing neurons and decreases concentration levels of striatal dopamine.

  2005cites this paper
• Hepatocyte transplantation

  2005cites this paper
• Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors

  2005cites this paper
• Hepatocyte transplantation.

  2004cites this paper
• Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide

  2004cites this paper
• HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia.

  2002cites this paper
• Book Review: Gene Therapy with Herpes Simplex Virus Vectors: Progress and Prospects for Clinical Neuroscience

  2001cites this paper
• Lebergentherapie: Aktueller Stand und Ausblick

  2001cites this paper
• Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia.

  2001cites this paper
• Gene delivery and gene therapy with herpes simplex virus-based vectors.

  2001cites this paper
• Gene therapy using herpes simplex virus-based vectors.

  2000cites this paper
• Gene-experience interaction alters the cholinergic septohippocampal pathway of mice.

  2000cites this paper
• The application of a lentiviral vector for gene transfer in fetal human hepatocytes

  2000cites this paper
• Ex vivo hepatocyte-directed gene therapy

  2000cites this paper
• Herpes Simplex Virus (HSV)-Mediated ICAM-1 Gene Transfer Abrogates Tumorigenicity and Induces Anti-Tumor Immunity

  1999cites this paper
• Gene therapy with herpes simplex virus vectors.

  1999cites this paper
• Gene therapy with herpes simplex virus vectors.

  1999cites this paper
• Differentiation‐specific regulation of transgene expression in a diploid epithelial cell line derived from the normal F344 rat liver

  1999cites this paper
• Simultaneous Up-regulation of Viral Receptor Expression and DNA Synthesis Is Required for Increasing Efficiency of Retroviral Hepatic Gene Transfer*

  1998cites this paper
• HSV-1 Amplicon

  1998cites this paper
• Hepatocyte transplantation: novel applications

  1998cites this paper
• Gene Therapy for Liver Disease

  1998cites this paper
• Transduction of human trophoblastic cells by replication-deficient recombinant viral vectors. Promoting cellular differentiation affects virus entry.

  1998cites this paper
• Gene Transfer into Hepatocytes Mediated by Helper Virus-Free HSV/AAV Hybrid Vectors

  1997cites this paper
• Mechanisms of trophoblast-virus interaction.

  1997cites this paper
• Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes.

  1997cites this paper
• Recombinant Virus‐mediated Gene Transfer in Trophoblast Cells

  1997cites this paper
• Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

  1997cites this paper
• Prolonged In Vivo Gene Expression Driven by a Tyrosine Hydroxylase Promoter in a Defective Herpes Simplex Virus Amplicon Vector

  1996cites this paper
• Baculovirus-mediated gene transfer into mammalian cells.

  1996cites this paper
• Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis.

  1996cites this paper
• Gene Transfer into Hepatocytes and Human Liver Tissue by Baculovirus Vectors

  1996cites this paper
• Adenovirus vector-transduced hepatocytes implanted via a preformed collagen/PTFE support persist for at least 4 weeks in vivo.

  1996cites this paper